free web stats

Your Drug Injury Case Will Benefit From Our Years of Experience

 

Experienced drug injury lawyer

Attorney Tom Lamb

We have been representing patients and their family in drug injury lawsuits for the past 16 years and this is our main practice area.

Drug injury legal compensation cases involve personal injury or wrongful death claims filed on behalf of people who, unfortunately, experienced a serious side effect, had an adverse drug reaction, or died from their use of a prescription medication.

Given our many years of experience handling these types of lawsuits we know drug injury cases deserve special attention.

Drug injury claims have a personal aspect which must be appreciated and respected by the attorney handling your case. At our law firm, we do not underestimate nor lose sight of the trust which is being placed in us by clients when they select us to represent them for their lawsuit against the responsible pharmaceutical company.

We will handle your drug injury case not only competently and professionally, but with genuine care and understanding. Any inquiries from our clients are responded to promptly, and telephone calls are always returned without delay.

If you, relatives, or friends need legal advice or legal representation for a personal injury lawsuit or a wrongful death lawsuit involving a drug side effect, the Law Offices of Thomas J. Lamb is here to help.

We encourage you to submit a Drug Injury Law Case Review — it is free, confidential, and there is no obligation.  Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case.  Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, or some other lawyer — about your case based on his many years of experience.

We handle these drug injury cases on a contingency fee basis, meaning that there is no payment for our legal services until we are successful in getting legal compensation for you.

While our office is in Wilmington, North Carolina, we have successfully handled drug injury lawsuits for people all over the United States.

It is important to note that we do not put our clients into large class actions. Rather we favor an individual lawsuit approach, which allows us to give personal attention to each of our clients, from start to finish.

___________________________________________________________

Legal & Medical News: Featured Article

 

Lyrica Use During Pregnancy Increases The Risk Of Major Birth Defects

Women who took Lyrica (pregabalin) while pregnant were about three times more likely to have babies with major birth defects compared with women who did not take Lyrica, according to study done by a team of medical researchers in Europe that was recently reported in the journal Neurology.

From the Abstract for this report, “Pregnancy outcome following maternal exposure to pregabalin may call for concern”, from the Neurology.org website (“Published online before print May 18, 2016”) we get an overview of the new Lyrica research:

Objective: To investigate pregnancy outcomes following maternal use of [Lyrica (pregabalin)].

Methods: This multicenter, observational prospective cohort study compared pregnancy outcomes in women exposed to [Lyrica (pregabalin)] with those of matched controls (not exposed to any medications known to be teratogenic or to any antiepileptic drugs)…

Conclusions: This study demonstrated a signal for increased risk of major birth defects after first trimester exposure to [Lyrica (pregabalin)]. However, several limitations such as the small sample size, differences across groups in maternal conditions, and concomitant medication exposure exclude definitive conclusions, so these results call for confirmation through independent studies.

From a May 19, 2016 Medpage Today article, “Human Birth Defects Seen With Pregabalin — Time for a pregnancy category change?”, we get this contextual information and commentary about this recent Lyrica – birth defects medical study:

The FDA currently classifies [Lyrica (pregabalin)] as pregnancy category C, indicating that teratogenic effects have been seen in animal studies but there are “no adequate and well controlled studies in pregnant women.” Whether the agency will revise [Lyrica (pregabalin)]’s label on the basis of the new study remains to be seen.

Max Wiznitzer, MD, of UH Rainbow Babies and Children’s Hospital in Cleveland, who was not involved in the study, said it raises important questions, but is “not definitive proof” that [Lyrica (pregabalin)] causes these birth defects because the study was small, doesn’t hone in on a single defect or syndrome and included many mothers-to-be who were also taking other medications. He said it warranted further research.

We will continue to monitor the medical literature for any more research done on this drug safety issue of pregnant women using Lyrica having an increased risk of having children with birth defects. We will also watch to see whether the FDA decides there should be any Lyrica label change, such as changing the pregnancy category for Lyrica.

[Read this article in full at original source]
 
 
Earlier articles by attorney Tom Lamb on the Side Effects Blog:

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, NC 28403
(800) 426-9535
[email protected]
Disclaimer and Copyright